Yao W - Search Results

1

CD4⁺ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.

Xiao M, Xie L, Cao G, Lei S, Wang P, Wei Z, Luo Y, Fang J, Yang X, Huang Q, Xu L, Guo J, Wen S, Wang Z, Wu Q, Tang J, Wang L, Chen X, Chen C, Zhang Y, Yao W, Ye J, He R, Huang J, Ye L. Xiao M, et al. Among authors: yao w. J Immunother Cancer. 2022 May;10(5):e004022. doi: 10.1136/jitc-2021-004022. J Immunother Cancer. 2022. PMID: 35580929 Free PMC article.

2

Analysis of FOS, BTG2, and NR4A in the function of renal medullary hypertension.

Wu YB, Zang WD, Yao WZ, Luo Y, Hu B, Wang L, Liang YL. Wu YB, et al. Among authors: yao wz. Genet Mol Res. 2013 Sep 19;12(3):3735-41. doi: 10.4238/2013.September.19.4. Genet Mol Res. 2013. PMID: 24085434 Free article.

3

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor.

Chen X, Li R, Pan Z, Qian C, Yang Y, You R, Zhao J, Liu P, Gao L, Li Z, Huang Q, Xu L, Tang J, Tian Q, Yao W, Hu L, Yan X, Zhou X, Wu Y, Deng K, Zhang Z, Qian Z, Chen Y, Ye L. Chen X, et al. Among authors: yao w. Cell Mol Immunol. 2020 Jun;17(6):647-649. doi: 10.1038/s41423-020-0426-7. Epub 2020 Apr 20. Cell Mol Immunol. 2020. PMID: 32313207 Free PMC article. No abstract available.

4

B7 score and T cell infiltration stratify immune status in prostate cancer.

Zhou Q, Li K, Lai Y, Yao K, Wang Q, Zhan X, Peng S, Cai W, Yao W, Zang X, Xu K, Huang J, Huang H. Zhou Q, et al. Among authors: yao k, yao w. J Immunother Cancer. 2021 Aug;9(8):e002455. doi: 10.1136/jitc-2021-002455. J Immunother Cancer. 2021. PMID: 34417325 Free PMC article.

5

The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4⁺ T cells by preventing ferroptosis.

Wang Y, Tian Q, Hao Y, Yao W, Lu J, Chen C, Chen X, Lin Y, Huang Q, Xu L, Hu J, Lei S, Wei Z, Luo Y, Li Z, Hu L, Tang J, Wu Q, Zhou X, Wu Y, Yin Z, Xu J, Ye L. Wang Y, et al. Among authors: yao w. Nat Immunol. 2022 Feb;23(2):303-317. doi: 10.1038/s41590-021-01090-1. Epub 2021 Dec 23. Nat Immunol. 2022. PMID: 34949833

6

Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases.

Liang X, Jiang Y, Yao W, Deng Y, Yang S, Liu Q. Liang X, et al. Among authors: yao w. Transl Cancer Res. 2024 Mar 31;13(3):1508-1518. doi: 10.21037/tcr-23-1333. Epub 2024 Mar 11. Transl Cancer Res. 2024. PMID: 38617508 Free PMC article.

7

Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in Melanoma.

Zhang G, Li S, Xiao W, Zhang C, Li T, Liao Z, Liu H, Xing R, Yao W, Yang J. Zhang G, et al. Among authors: yao w. Cancers (Basel). 2024 Feb 23;16(5):908. doi: 10.3390/cancers16050908. Cancers (Basel). 2024. PMID: 38473271 Free PMC article.

8

Encouraging efficacy of a comprehensive therapy consisting of sintilimab, bevacizumab biosimilar IBI305, hypo-fractionated intensity-modulated radiotherapy, and oxaliplatin for a maxillary metastasis from hepatocellular carcinoma: A case report and literature review.

Liang X, Liu Q, Yao W, Zhu S. Liang X, et al. Among authors: yao w. Front Oncol. 2022 Nov 23;12:941454. doi: 10.3389/fonc.2022.941454. eCollection 2022. Front Oncol. 2022. PMID: 36505782 Free PMC article.

9

Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study.

Jin YN, Ruan ZH, Cao WW, Yang L, Yao W, Pei XF, Zhang WJ, Marks T, Yao JJ, Xia LP. Jin YN, et al. Among authors: yao w, yao jj. J Cancer Res Clin Oncol. 2023 Oct;149(13):11929-11940. doi: 10.1007/s00432-023-05041-1. Epub 2023 Jul 7. J Cancer Res Clin Oncol. 2023. PMID: 37418058

10

Noninvasive Method for Predicting the Expression of Ki67 and Prognosis in Non-Small-Cell Lung Cancer Patients: Radiomics.

Yao W, Liao Y, Li X, Zhang F, Zhang H, Hu B, Wang X, Li L, Xiao M. Yao W, et al. J Healthc Eng. 2022 Mar 16;2022:7761589. doi: 10.1155/2022/7761589. eCollection 2022. J Healthc Eng. 2022. PMID: 35340222 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,044 results

Search Page